Transforming Allergy Treatment

Media Centre

Latest News

March 02.2010

Interim Results and £2.0 million Fundraising

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines announces interim results for the six months ended 31 December 2009.

September 21.2009

Preliminary Results for the year ended 30 June 2009

September 01.2009

Confirmation of Management Change

July 23.2009

European Patent Granted For MPL-Based Sublingual Vaccines

June 12.2009

Proposed Placing and Subscription Offer to Qualifying Participants Approval of waiver of Takeover Code Rule 9 and Notice of General Meeting

April 08.2009

Distribution Agreement with Nycomed for Pollinex® R in Canada

March 31.2009

Interim Results for the six months ended 31 December 2008

March 04.2009

Pollinex® Quattro Grass Dossier Submitted for European Union ('EU') Regulatory Review

September 22.2008

Preliminary Results for the year ended 30 June 2008